DABRAFENIB for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 610 adverse event reports in the FDA FAERS database where DABRAFENIB was used for Lung neoplasm malignant.
Most Reported Side Effects for DABRAFENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 3,788 | 19.6% | 352 | 1,599 |
| Death | 2,740 | 14.2% | 2,733 | 198 |
| Malignant neoplasm progression | 1,667 | 8.6% | 693 | 496 |
| Fatigue | 1,328 | 6.9% | 135 | 338 |
| Nausea | 1,300 | 6.7% | 178 | 450 |
| Chills | 1,235 | 6.4% | 90 | 419 |
| Rash | 1,078 | 5.6% | 82 | 244 |
| Vomiting | 907 | 4.7% | 122 | 445 |
| Diarrhoea | 901 | 4.7% | 103 | 357 |
| Headache | 697 | 3.6% | 69 | 228 |
| Asthenia | 667 | 3.5% | 124 | 289 |
| Malaise | 585 | 3.0% | 86 | 237 |
| Decreased appetite | 546 | 2.8% | 110 | 215 |
| Arthralgia | 539 | 2.8% | 40 | 146 |
| Product use in unapproved indication | 504 | 2.6% | 94 | 60 |
Other Indications for DABRAFENIB
Malignant melanoma (5,277)
Product used for unknown indication (4,430)
Metastatic malignant melanoma (3,885)
Thyroid cancer (583)
Non-small cell lung cancer (557)
Neoplasm malignant (356)
Braf gene mutation (224)
Braf v600e mutation positive (213)
Malignant melanoma stage iv (197)
Brain neoplasm malignant (189)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)